Filing Details
- Accession Number:
- 0001209191-14-065273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-29 17:19:52
- Reporting Period:
- 2014-10-27
- Filing Date:
- 2014-10-29
- Accepted Time:
- 2014-10-29 17:19:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187574 | Stuart Essig | 311 C Enterprise Drive Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-10-27 | 41,268 | $34.49 | 998,077 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-10-27 | 41,268 | $49.56 | 956,809 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-10-28 | 105,830 | $34.49 | 1,062,639 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-10-28 | 105,830 | $49.59 | 956,809 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-10-27 | 41,268 | $0.00 | 41,268 | $34.49 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-10-28 | 105,830 | $0.00 | 105,830 | $34.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
158,732 | 2014-12-17 | No | 4 | M | Direct | |
52,902 | 2014-12-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $49.50 to $49.74.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $49.50 to $49.79.
- 25% of the option grant vested on 12/17/2005 (the first anniversary of the grant date of 12/17/2004), and the remaining 75% vested monthly thereafter over 36 months.